Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
deals
3
×
life sciences
national blog main
new york blog main
new york top stories
san francisco blog main
san francisco top stories
biotech
cancer drugs
clinical trials
eli lilly
fda
medicare
national
national top stories
acute myeloid leukemia
adaptive biotechnologies
alector
allergan
alx oncology
amgen
apollomics
autoimmune diseases
berkeley lights
bernie sanders
beta bionics
bill & melinda gates foundation trust
biontech
biotech ipos
black diamond therapeutics
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
cd47
What
hasn’t
3
×
bio
cancer
companies
new
pharmaceutical
appetite
arrival
bets
biotech
black
bread
butter
buyout
cash
comes
cut
date
days
deal
diabetes
diamond’s
drugs
effective
eli
enticed
evidence
giant
grabbed
hold
industry
ipo
ipos
latest
life
lilly's
lost
loxo
market
medicines
Language
unset
Current search:
hasn’t
×
deals
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
